Page 5 of 6
The table below shows the number of patients (percent) with serious side effects
reported during the study.
Number of patients (percent) with serious side effects
DHA-PQP alone TQ and DHA-PQP PQ and DHA-PQP
50 patients 50 patients 50 patients
Abnormally high blood
0 0 1 (2%)
pressure
Heart rhythm problem 1 (2%) 0 0
The table below shows the number of patients (percent) with non-serious side effects
that were reported by 4% or more of patients in any treatment group.
Number of patients (percent) with non-serious side effects
reported by 4% or more of patients
DHA-PQP alone TQ and DHA-PQP PQ and DHA-PQP
50 patients 50 patients 50 patients
Vomiting 1 (2%) 3 (6%) 0
Weakness 3 (6%) 1 (2%) 1 (2%)
Diarrhoea 2 (4%) 2 (4%) 1 (2%)
Headache 2 (4%) 2 (4%) 1 (2%)
Indigestion 0 0 2 (4%)
Pain in stomach 0 0 2 (4%)
How has this study helped patients and researchers?
The study showed that more patients in the TQ and DHA-PQP group compared with the
DHA-PQP alone group remained malaria-free for six months after treating the initial
malaria. This difference was not big enough for researchers to conclude that a